FRANKLIN LAKES, N.J., June 3 /PRNewswire-FirstCall/ -- BD (Becton,
Dickinson and Company) (NYSE: BDX), a global medical technology company,
announced today that it would present at the Goldman Sachs Twenty-Ninth
Annual Global Healthcare Conference on Wednesday, June 11, 2008, at 4:20
p.m. (ET).
The live webcast of BD's presentation can be accessed from the BD
corporate website at http://www.bd.com/investors and will be available for replay
through Wednesday, June 18, 2008.
BD, a leading global medical technology company that manufactures and
sells medical devices, instrument systems and reagents, is dedicated to
improving people's health throughout the world. BD is focused on improving
drug therapy, enhancing the quality and speed of diagnosing infectious
diseases, and advancing research and discovery of new drugs and vaccines.
The Company's capabilities are instrumental in combating many of the
world's most pressing diseases. Founded in 1897 and headquartered in
Franklin Lakes, New Jersey, BD employs approximately 28,000 people in
approximately 50 countries throughout the world. The Company serves
healthcare institutions, life science researchers, clinical laboratories,
industry and the general public. For more information, please visit
http://www.bd.com.
'/>"/>SOURCE BD (Becton, Dickinson and Company) Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 Related medicine news :1.
Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vails Teva Mountain Games2.
American College of Rheumatology presents recommendations for rheumatoid arthritis therapy3.
Medco CEO to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference4.
Canine Cancer Web Exclusive for Dog Owners and Lovers, Presented by Morris Animal Foundation - Features Colorado State and Cornell University Veterinary Cancer Experts5.
Medifast, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference6.
Childrens Health and Fitness To Be Focus of ING Presents Marc Anthony Juntos en Concierto Series7.
Latest Advances in Infection Prevention and Control to be Presented in Denver, CO at Worlds Largest Annual Infection Prevention Conference, June 15-19, 20088.
Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference9.
Isis Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology10.
Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference11.
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting